Loading...
C21 Investments Inc.
CXXI.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.38
$-0.02(-5.00%)
Canadian Market opens in 14h 53mC21 Investments Inc. (CXXI.CN) AI-Powered Stock Analysis
See how C21 Investments Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerC21 Investments Inc. (CXXI.CN) Stock Overall Grade
C21 Investments Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to C21 Investments Inc.'s overall stock rating.
Forecast
C+Score
55/100Financial Growth
BScore
60/100Fundamental Growth
C+Score
57/100Key Ratios
BScore
63/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100C21 Investments Inc. (CXXI.CN) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (57/100, C+) highlight its stability, while Key Ratios (63/100, B) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each C21 Investments Inc. stock grade, including financials, comparisons, and forecasts.